Literature DB >> 9142781

Early detection of sequela-prone osteomyelitis in children with use of simple clinical and laboratory criteria.

I Roine1, A Arguedas, I Faingezicht, F Rodriguez.   

Abstract

To determine which clinical or laboratory criteria best reflected the prognosis for 83 children with acute hematogenous osteomyelitis (AHO), they were compared with outcomes after a follow-up of at least 2 months (for 78%, > or = 6 months). Twenty-eight children (34%) developed sequelae. They had higher serum C-reactive protein (CRP) concentrations (days 1-6 of treatment; P = .0004 to .0001) and higher clinical scores (P = .0001) than did patients who had an uneventful recovery. The frequency of sequelae increased from 3% to 73% (P = .0001) when CRP concentrations exceeded the defined cutoff limits and the clinical scores were > or = 1. Age, the duration of symptoms at diagnosis, and the type and duration of intravenous antimicrobial therapy or surgical management did not differ (P > .05) between children with and without sequelae. Both CRP determinations and clinical evaluations with use of a scoring system enable early detection of sequela-prone AHO in children and are most accurate when used together.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9142781     DOI: 10.1093/clinids/24.5.849

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

Review 1.  Acute hematogenous osteomyelitis in children: recognition and management.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

2.  Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.

Authors:  Ashwin Balagopal; David M Asmuth; Wei-Teng Yang; Thomas B Campbell; Nikhil Gupte; Laura Smeaton; Cecilia Kanyama; Beatriz Grinsztejn; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R Lama; Umesh G Lalloo; Fatima Zulu; Jyoti S Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Xiao-Dong Li; Richard B Pollard; Richard D Semba; David L Thomas; Robert C Bollinger; Amita Gupta
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.731

3.  Fosfomycin for the initial treatment of acute haematogenous osteomyelitis.

Authors:  N Corti; F H Sennhauser; U G Stauffer; D Nadal
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

4.  Predicting Outcome of Childhood Bacterial Meningitis With a Single Measurement of C-Reactive Protein.

Authors:  Heikki Peltola; Tuula Pelkonen; Irmeli Roine; Manuel Leite Cruzeiro; Luis Bernardino
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

5.  Laboratory predictors for risk of revision surgery in pediatric septic arthritis.

Authors:  Jessica J M Telleria; Rosemary A Cotter; Viviana Bompadre; Suzanne E Steinman
Journal:  J Child Orthop       Date:  2016-05-12       Impact factor: 1.548

6.  Factors predictive of relapse in adult bacterial osteomyelitis of long bones.

Authors:  E Garcia Del Pozo; J Collazos; J A Carton; D Camporro; V Asensi
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

7.  C-Reactive Protein Level at Time of Discharge Is Not Predictive of Risk of Reoperation or Readmission in Children With Septic Arthritis.

Authors:  Maryse Bouchard; Lara Shefelbine; Viviana Bompadre
Journal:  Front Surg       Date:  2019-12-03

8.  Late sequelae of osteoarticular infections in pediatric patients: A single-center study.

Authors:  Lydia Saad; Mathilde Hupin; Chantal Buteau; Marie-Lyne Nault
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

9.  Prediction of Adverse Outcomes in Pediatric Acute Hematogenous Osteomyelitis.

Authors:  Zaid Alhinai; Morvarid Elahi; Sangshin Park; Bill Foo; Brian Lee; Kimberle Chapin; Michael Koster; Pablo J Sánchez; Ian C Michelow
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

Review 10.  Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review.

Authors:  Nicole Le Saux; Andrew Howard; Nicholas J Barrowman; Isabelle Gaboury; Margaret Sampson; David Moher
Journal:  BMC Infect Dis       Date:  2002-08-14       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.